Association of polymorphic markers of the <i>XRCC1</i>, <i>ERCC5</i>, <i>TP53</i>, <i>CDKN1A1</i> genes with the survival of patients after platinum-based chemotherapy for triple negative breast cancer

• Main Authors: T. M. Zavarykina (Author), P. K. Lomskova (Author), M. A. Kapralova (Author), O. O. Gordeeva (Author), I. P. Ganshina (Author), D. S. Khodyrev (Author), S. V. Khokhlova (Author), I. V. Kolyadina (Author)
• Format: Book
• Published: ABV-press, 2023-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background. Breast cancer is the most common cancer among women. Triple negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, in which there are no special targets for therapy. Therefore chemotherapy is still leading treatment for TNBC including the regiments with platinum d...